JP2022546414A5 - - Google Patents
Info
- Publication number
- JP2022546414A5 JP2022546414A5 JP2022513164A JP2022513164A JP2022546414A5 JP 2022546414 A5 JP2022546414 A5 JP 2022546414A5 JP 2022513164 A JP2022513164 A JP 2022513164A JP 2022513164 A JP2022513164 A JP 2022513164A JP 2022546414 A5 JP2022546414 A5 JP 2022546414A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independent
- halo
- deutherium
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893528P | 2019-08-29 | 2019-08-29 | |
| US62/893,528 | 2019-08-29 | ||
| PCT/US2020/048621 WO2021041975A1 (en) | 2019-08-29 | 2020-08-28 | Perk inhibiting pyrrolopyrimidine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546414A JP2022546414A (ja) | 2022-11-04 |
| JP2022546414A5 true JP2022546414A5 (cg-RX-API-DMAC7.html) | 2023-08-28 |
Family
ID=72470610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513164A Pending JP2022546414A (ja) | 2019-08-29 | 2020-08-28 | Perk阻害ピロロピリミジン化合物 |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021041973A1 (en) | 2019-08-29 | 2021-03-04 | Hibercell, Inc. | Perk inhibiting compounds |
| CA3182276A1 (en) | 2020-05-08 | 2021-12-02 | Halia Therapeutics, Inc. | Inhibitors of nek7 kinase |
| CN117597346A (zh) * | 2021-04-05 | 2024-02-23 | 哈利亚治疗公司 | Nek7抑制剂 |
| JP2024513227A (ja) * | 2021-04-05 | 2024-03-22 | ハリア・セラピューティクス・インコーポレイテッド | Nek7阻害剤 |
| US20240287081A1 (en) * | 2021-06-09 | 2024-08-29 | Icahn School Of Medicine At Mount Sinai | Perfluoroalkane substituted pyrazolo[3,4-d]pyrimidin and pyrrolo[2,3-d]pyrimidin compounds and uses thereof |
| US20250000859A1 (en) | 2021-08-25 | 2025-01-02 | Alesta Therapeutics BV | Use of gcn2 inhibitors in treating cancer |
| GB202407386D0 (en) | 2024-05-24 | 2024-07-10 | Apollo Ap45 Ltd | 1H-pyrazolo(4,3-D)pyrimidine derivatives |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3903297A (en) | 1973-11-01 | 1975-09-02 | Upjohn Co | Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs |
| BR9808281A (pt) * | 1997-03-19 | 2000-05-16 | Basf Ag | Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto |
| US7863444B2 (en) * | 1997-03-19 | 2011-01-04 | Abbott Laboratories | 4-aminopyrrolopyrimidines as kinase inhibitors |
| US8598156B2 (en) | 2010-03-25 | 2013-12-03 | Glaxosmithkline Llc | Chemical compounds |
| EP3067356B1 (en) * | 2013-11-08 | 2018-07-04 | ONO Pharmaceutical Co., Ltd. | Pyrrolo pyrimidine derivative |
| WO2016004254A1 (en) | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
| WO2016085160A2 (ko) * | 2014-11-28 | 2016-06-02 | (주)네오팜 | 발모촉진용 또는 탈모방지용 조성물 |
| GB201508747D0 (en) * | 2015-05-21 | 2015-07-01 | Univ Edinburgh | Compounds |
| WO2017046739A1 (en) * | 2015-09-15 | 2017-03-23 | Glaxosmithkline Intellectual Property (No.2) Limited | Imidazolidinone derivatives as inhibitors of perk |
| TW201722957A (zh) * | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產(第二)有限公司 | 化學化合物 |
| EP3481831B1 (en) * | 2016-07-07 | 2023-09-06 | Daewoong Pharmaceutical Co., Ltd. | 4-aminopyrazolo[3,4-d]pyrimidinylazabicyclo derivatives and pharmaceutical composition comprising the same |
| SI3612519T1 (sl) * | 2017-04-18 | 2022-04-29 | Eli Lilly And Company | Fenil-2-hidroksi-acetilamino-2-metil-fenilne spojine |
-
2020
- 2020-08-28 KR KR1020227010197A patent/KR20220066290A/ko not_active Ceased
- 2020-08-28 BR BR112022003584A patent/BR112022003584A2/pt not_active IP Right Cessation
- 2020-08-28 EP EP20771405.6A patent/EP4021908A1/en not_active Withdrawn
- 2020-08-28 MX MX2022002446A patent/MX2022002446A/es unknown
- 2020-08-28 US US17/639,279 patent/US20220356186A1/en active Pending
- 2020-08-28 PH PH1/2022/550491A patent/PH12022550491A1/en unknown
- 2020-08-28 CA CA3152508A patent/CA3152508A1/en active Pending
- 2020-08-28 CN CN202080073530.2A patent/CN114710956A/zh active Pending
- 2020-08-28 AU AU2020336975A patent/AU2020336975A1/en not_active Abandoned
- 2020-08-28 JP JP2022513164A patent/JP2022546414A/ja active Pending
- 2020-08-28 WO PCT/US2020/048621 patent/WO2021041975A1/en not_active Ceased
-
2022
- 2022-02-24 IL IL290889A patent/IL290889A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010531345A5 (cg-RX-API-DMAC7.html) | ||
| US20140011798A1 (en) | Imidazopyrrolidinone compounds | |
| JP2019517487A5 (cg-RX-API-DMAC7.html) | ||
| JP2013544893A5 (cg-RX-API-DMAC7.html) | ||
| RU2005119151A (ru) | Производные пиридазинона в качестве gsk-3бета-ингибиторов | |
| US20230159514A1 (en) | Compositions and methods for inhibiting kinases | |
| RU2017121044A (ru) | Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы | |
| BR112012017713A2 (pt) | Aminopiridina, formulação farmacêutica, processo para a preparação de um derivado de aminopiridina, intermediário, e, uso de uma aminopiridina ou de uma formulação farmacêutica | |
| JP2000001434A (ja) | コルチコトロピン放出因子アンタゴニストを含む医薬組成物 | |
| JP2018529770A5 (cg-RX-API-DMAC7.html) | ||
| RU2008110913A (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО[4,5-b]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ ГЛИКОГЕНСИНТАЗЫ 3 ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ДЕМЕНЦИИ И НЕЙРОДЕГЕНЕРАТИВНЫХ РАССТРОЙСТВ | |
| RU2003121307A (ru) | (диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета | |
| US20240245634A1 (en) | Pcna inhibitors and egfr inhibitors for cancer treatment | |
| RU2018112993A (ru) | Соединения и способы для ингибирования JAK | |
| CA2568608A1 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| CA2803055A1 (en) | Heteroaryl compounds and compositions as protein kinase inhibitors | |
| RU2017145928A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| CN102647986A (zh) | 治疗增殖性障碍和其它由bcr-abl、c-kit、ddr1、ddr2或pdgf-r激酶活性介导的病理学病症的方法 | |
| JP2023547396A5 (cg-RX-API-DMAC7.html) | ||
| WO2013082324A1 (en) | Improved modulators of hec1 activity and methods therefor | |
| JP2015131865A (ja) | 抗癌用医薬 | |
| US20190030009A1 (en) | Compounds and compositions for the treatment of cryptosporidiosis | |
| AU2017205389A1 (en) | Benzothiazole amphiphiles | |
| CA2564574A1 (en) | Use of c-kit inhibitors for treating fibrosis | |
| RU2015101211A (ru) | Производное имидазопиридина, используемое для лечения сахарного диабета |